NEW YORK (GenomeWeb News) – CombiMatrix said after the close of the market on Friday that it raised $1.45 million in a second tranche of its Series A Preferred Stock.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: the Human Silencing Hub protein complex, and more.
Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.
The Kansas City Star examines issues surrounding newborn genome sequencing.
Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.